It is sad that there is a grab at corruption and wealth for

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps TechGuru #66566
716
It is sad that there is a grab at corruption and wealth for some pharmaceutical companies. Not just here but around the world. Like Your example in India.

I wonder what the driving forces are beside just money for the current big Pharmaceutical company. Is there real hope that science will prevail and even though they have no repeatable verified proof of efficacy. Yet they seek approval just for the mighty dollar? Hoping nobody will say that it doesn’t work? Does it matter that it didn’t work to them? Will they be forced to repay the money like the 500 million the E.U. spent the day before WHO came out and said Remdesivir doesn’t do anything. Will they repay the money the US spent too and any other country that bought Remdesivir? Will they have to be sued after the pandemic. What liability will Gilead have for those bamboozled by Gilead? How much liability will the FDA have in this, not only EUA but BLA full approval? How do they justify full approval without improved results after the EUA?

I wonder if there is a free pass written into these pandemic situations where drugs are immune from liability and maybe the FDA are also immune during this time? If immunity is somehow true then this is a huge corruptible situation. What are the reasons anyone would be involved in this unfounded situation of approvals. Is it only grab the money before they figure out we don’t really work? Is it the government hoping the modest at best results will give hope to the people that need critical help most? That hope alone is so important to healing some people. How does one justify these moves from either position? Government regulator or pharmaceutical.

Why is there this grab at huge money with just hope and a prayer that it might work? Some companies like us pay the price and have to prove without a doubt we work but some companies push and push to sew ideas of miracles that don’t really happen and get preferred handling.

There use to be a time that the government performed these trials and the trials must of been much more fair for all companies. No money influence dominated. Maybe as a country or a world society we need to return to those days before the next pandemic? Maybe it’s time to not let the fox watch the hen house and hope the Fox doesn’t take what he wants when he wants. Maybe it time that the science truly dictates and the government levels the playing field amongst all companies striving to save lives by government controlled trials again?

Do we need HHS and FDA reform? Should the government do the trials for the drug companies like they use to? Will the world be smart enough to change the process for what we know will undoubtedly happen again in the next pandemic? Can we afford to let all this happen again?

Can we change the worlds perception of big Pharma’s dominance politically to make a level playing field? I believe it starts with political donations to our elected officials. Change the power of the businesses in this country and put it back in the hands of the people. Stop business donations to any political race or candidate. This influence is ruining our country and it really shows now in a pandemic more than ever. The average American isn’t doing better competing with big business for a government that was designed for the people by the people. I don’t remember it having business for the business anywhere in the constitution.

Sorry for the rant

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wolfbox K7 Pro: Night Driving's New Guardian

Updated Category News Views 99

Driving Under the Stars with the K7 Pro Let's be real here, night driving can give anyone a touch of the heebie-jeebies. Crunch time on the road when the lights dim and the stakes rise. Enter the Wolfbox K7 Pro, tailormade for these nocturnal journeys. This dash cam's no slouch—it packs a punch with true-blue 4K recording front and back. We're talking sharp images, even...

Continue Reading
Maple Leaf Foods' Q3 Results: Growth Amidst Inflation

Updated Category News Views 35

Navigating Inflationary Waters: A Maple Leaf Foods Update Seeing Maple Leaf Foods (TSX: MFI) push through a tough inflationary landscape with a 15.4% rise in EBITDA would make any seasoned investor nod in respect. They've gone from last year's $111.7 million to a hefty $129 million in Q3 2026. What's more, their EBITDA margin climbed to 12.5%, up 140 basis points from...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 53

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
Tarte's Record-Breaking Collab: 60 Seconds to Sellout

Updated Category News Views 82

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Illinois House Democrats Surge with Historic Gaines

Updated Category News Views 62

Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...

Continue Reading
UP Fintech Faces Major Class Action Amid Chinese Regulatory Hurdles

Updated Category News Views 110

Legal Battles Loom Over UP Fintech UP Fintech Holding Limited, trading under NASDAQ: TIGR, is knee-deep in legal mire, thanks to a hefty class action lawsuit. Levi & Korsinsky rings the legal bells for shareholders who grabbed TIGR securities from April 22, 2024, to June 2, 2026. The heat is on—a December 28, 2026 deadline for lead plaintiff spot beckons. Dust off those...

Continue Reading
Mazu Forum: Bridging Cultures and Marine Safety

Updated Category News Views 93

The 11th Global Mazu Culture Forum kicked off on November 1 in Putian City, Fujian Province—smack dab on the historical Meizhou Island. This ain’t just another talk-fest; it's a melting pot of ideas and achievements packaged with cultural flair and some serious tech muscle. Nestled in China's southeast, Meizhou Island serves as the heartland for Mazu culture, a beacon...

Continue Reading
Gildan Faces Fraud Lawsuit: Investors Can Lead Case

Updated Category News Views 63

Everyone's been dreaming about jackpot profits, huh? Well, for those holding onto Gildan Activewear Inc. (NYSE: GIL) shares, that bubble just popped. We're staring at a class-action lawsuit for securities fraud, accusing the company of cooking the books. Time for Wall Street's soap opera, folks. Understanding the Allegations Let's get to the grit. According to the lawsuit...

Continue Reading
Salomon Trail Week: International Bonding Over Trails

Updated Category News Views 86

A Weeklong Trail Adventure There's nothing quite like shaking off the cobwebs with a splash of mountain air mixed with a dash of raw athleticism. Salomon Trail Week wrapped up over in Linhai, China, marking yet another notch in the belt of trail running culture. This wasn't just a mere stampede over scenic trails but a full-on celebration of the global and Chinese trail...

Continue Reading
: Revenue Hits $100M - Continue Reading" aria-label="Continue reading: Fractal Sees Explosive Q2 Gain: Revenue Hits $100M"> Continue Reading